Neurodevelopmental Disorder

Researchers performed a systematic review of PubMed literature until May
2020 including clinical sequencing studies that utilized next-generation sequencing (NGS) in individuals with epilepsy, autism spectrum disorder (ASD), or intellectual disability (ID).